Sign in
4

Changes in Ownership

KYNTRA BIO, INC. Filed Acc 0001209191-23-036078

Director sold 8,520 shares at an average $17.44 ($148,591)

  • Director acquired 8,289 shares (grant or award)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Ho Maykin · Director

Table I: Non-derivative

3 lines
Date Transaction Shares Price Value Owned after D/I
2023-06-07 Grant or award : show line 1 in the form 10b5-1 +8,289 40,021 D
2023-06-08 Sale : show line 2 in the form 10b5-1 −2,295 $16.79 $38,533 37,726 D
2023-06-08 Sale : show line 3 in the form 10b5-1 −6,225 $17.68 $110,058 31,501 D
Open-market sales · 8,520 sh · avg $17.44 · $148,591

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2023-06-07 Grant or award : show line 4 in the form 10b5-1 Stock Option (Right to Buy) +12,666 12,666 D
Loading xslF345X04/doc4.xml…